The GAL/GALR system has been described in glioma [30,118] in which the most abundant receptor observed was GAL1R, followed by GAL3R; GAL2R was not found (astrocytic/oligodendroglia tumors) [30] (Table 4). This evidence concerns the gene GALR3 and central nervous system cancer.